elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40456744-1D08542B-38A0-4070-B4C1-D75146AC1283
Q40456744-1D08542B-38A0-4070-B4C1-D75146AC1283
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40456744-1D08542B-38A0-4070-B4C1-D75146AC1283
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.
P921
Q40456744-1D08542B-38A0-4070-B4C1-D75146AC1283
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40456744-1D08542B-38A0-4070-B4C1-D75146AC1283
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
82630af7e1151e88e8ae34ab9d05aea66cb2f3b3
P921
thromboembolism